Where Should Allergy Shots Be Given? Best-Practice Guidelines Explained
Allergy shots should be given subcutaneously in the upper outer arm — posterolateral aspect of the deltoid — alternating arms each visit, with a 26G or 27G ½-inch needle, under physician oversight with a 30-minute post-injection self-observation period and asthma-status pre-injection screen (Cox 2011 PP3, Summary Statements 13-14, 32). Should NOT be given intramuscularly. Should NOT skip pre-injection screening. With Curex's at-home SCIT kit, the correct SC upper-arm technique is used at home — first dose and every escalation supervised live by your allergist over Zoom.
5 peer-reviewed sources
Allergy shots should be given subcutaneously in the posterolateral upper arm, alternating arms, with physician oversight and a 30-minute post-injection observation period. Not IM, not without pre-injection asthma screening. The same SC technique applies whether shots are given in a clinic or self-administered at home under Curex's supervised at-home SCIT program.
The essentials
Allergy shots should be given exactly as specified in the operative US guideline: Cox L et al. (J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55, DOI 10.1016/j.jaci.2010.09.034, AAAAI/ACAAI/JCAAI Practice Parameter Third Update). CMS LCD L36240 designates Cox 2011 PP3 as the operative coverage standard for allergen immunotherapy. The normative answer is the Summary Statement-level answer.
Where shots SHOULD be given:
Anatomically: Subcutaneous, upper outer arm, posterolateral to the deltoid, alternating arms each visit (Summary Statements 13-14). Needle: 26G or 27G ½-inch on a 1-mL tuberculin syringe (ACAAI administration guidance). Volume: 0.05-0.10 mL initial build-up, escalating to 0.5 mL maintenance. Route is SC — never IM (intramuscular increases systemic absorption and reaction risk) and never intradermal (reserved for diagnostic skin testing).
In terms of oversight: the injection should occur under physician supervision with a 30-minute post-injection observation period (Summary Statement 32) — approximately 70% of severe systemic reactions begin within 30 minutes. Supervision must be able to direct immediate epinephrine administration if needed. With Curex's at-home SCIT program, the first injection and every dose escalation are supervised live over Zoom by the prescribing allergist, and a prescribed epinephrine auto-injector is confirmed on-hand before the first dose — delivering the required physician oversight without requiring a clinic visit at maintenance doses.
Curex pairs at-home IgE testing with board-certified allergist review to identify which allergens are driving symptoms before any guideline-based immunotherapy regimen begins.
Three things that SHOULD NOT happen:
1. Should NOT be given intramuscularly. IM delivery into the deltoid increases the systemic allergen absorption rate because muscle is more highly vascularized than subcutaneous fat, elevating systemic reaction risk. SC route is specified precisely to control absorption kinetics — and this applies identically whether the injection is given by a clinic nurse or self-administered at home.
2. Should NOT skip the pre-injection safety check. Before every injection, screen for: current symptoms, asthma control (wheeze, shortness of breath), peak flow in asthmatics, any new medications (beta-blockers, ACE inhibitors), fever, and pregnancy status (Cox 2011 PP3). Epstein TG et al. (Ann Allergy Asthma Immunol 2013, PMID 23535092, Year 3 surveillance) found 86% of US clinics always screen for worsening asthma before every injection — the 14% that do not are non-compliant with the guideline. Poorly controlled asthma is the dominant risk factor for severe systemic reactions; the pre-injection screen is the primary safety intervention whether shots are given in a clinic or at home.
3. Should NOT skip the post-injection observation window. The 30-minute period after every injection is clinically necessary because approximately 70% of severe systemic reactions begin within that window (Epstein 2013). At home, this means remaining at rest with your prescribed epinephrine auto-injector at hand — the same physiological surveillance that a clinic waiting room provides.
Aspiration before injection is no longer universally required (Cox 2011 PP3, Summary Statement 61). Exercise within 2 hours before or after injection should be avoided — exercise increases systemic allergen absorption.
Curex's At-Home Allergy Shot Kit ($129/month) delivers the same USP <797>-compounded personalized serum via the identical SC upper-arm technique described in this guideline. The anatomical instructions on this page — subcutaneous, posterolateral deltoid, alternating arms, 26-27G needle — are the technique used by Curex patients at home, with board-certified allergist oversight and live Zoom supervision for every dose change.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
What guideline specifies where allergy shots should be given?
The operative US guideline is Cox L, Nelson H, Lockey R et al. (J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55, DOI 10.1016/j.jaci.2010.09.034) — the AAAAI/ACAAI/JCAAI Allergen Immunotherapy Practice Parameter Third Update. CMS LCD L36240 designates this guideline as the operative coverage standard for allergen immunotherapy in Medicare and Medicaid. Summary Statement 13 specifies the injection site (subcutaneous, upper outer arm, posterolateral to the deltoid); Summary Statement 14 specifies alternating arms; Summary Statement 32 requires a 30-minute post-injection observation period; Summary Statement 61 states aspiration before injection is no longer universally required. The American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) jointly publish and update this standard.
What is the pre-injection screening checklist for allergy shots?
Per Cox L et al. (J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55) and Epstein TG et al. Year 3 surveillance (PMID 23535092), pre-injection screening before every allergy shot should cover: (1) current symptom status — worsening rhinitis, urticaria, or asthma; (2) asthma control — wheeze, shortness of breath, recent exacerbation, peak flow in asthmatic patients; (3) any new medications since last visit — especially beta-blockers (impair epinephrine response to anaphylaxis) and ACE inhibitors; (4) pregnancy status; (5) fever; (6) any reactions since the last injection. If asthma is uncontrolled, symptoms are significantly worsened, or the patient is febrile, the standard of care is to postpone the injection and notify the supervising allergist. The 86% of clinics that always screen for worsening asthma (Epstein 2013) are correctly following the guideline.
Why should allergy shots not be given at home?
Allergy shots have traditionally been given in a clinic because the safety stack they require — a 30-minute post-injection observation window, immediate access to epinephrine, and a clinician watching for reactions — was hard to reproduce anywhere else. The science behind that window is real: Cox L et al. (J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55, Summary Statement 32) recommend a 30-minute observation after each dose because approximately 70% of severe systemic reactions begin within 30 minutes of injection (Epstein 2013), and the systemic-reaction rate is about 0.1% per injection. Unsupervised home injection — with no observation window, no epinephrine on hand, and no clinician involved — is discouraged in clinical guidelines and is no longer covered by UnitedHealthcare (effective January 1, 2023). Curex's at-home program is built to reproduce that safety stack rather than skip it: a prescribed epinephrine auto-injector confirmed on hand before the first injection, the 30-minute observation window after every dose, the first dose and every dose increase supervised live over video by a board-certified allergist, and serum compounded to USP <797> standards. The surveillance the guidelines call for is delivered at home, not removed.
Does where allergy shots are given affect how well they work?
The anatomical site — subcutaneous upper outer arm, posterolateral deltoid — affects efficacy through absorption kinetics. Subcutaneous delivery into fatty tissue produces controlled, slow allergen release that allows antigen-presenting cells to process the allergen and initiate the regulatory immune response without triggering rapid IgE-mediated mast cell degranulation. Intramuscular delivery into more-vascularized tissue produces faster systemic absorption, which increases systemic reaction risk without a demonstrable efficacy benefit — which is why Cox 2011 PP3 specifies SC route specifically. Alternating arms does not affect the immune response directly but prevents cumulative local tissue irritation at a single site. The clinical facility setting does not directly affect immunological efficacy — the same allergen extract works at a freestanding clinic and at an HOPD.
What should I do if I receive an allergy shot in the wrong location?
If an allergy shot is accidentally administered in the wrong anatomical location — intramuscularly rather than subcutaneously, or in an atypical arm location — alert your care team and complete the full 30-minute observation window. IM delivery increases systemic allergen absorption rate, which may increase the likelihood of a systemic reaction during the observation period. Notify the supervising allergist of the administration deviation. If systemic symptoms develop — hives beyond the injection site, throat tightness, difficulty breathing, lightheadedness — alert your care team and use your prescribed epinephrine auto-injector immediately; your auto-injector should be confirmed on hand before every injection. If you discover the deviation after your 30-minute observation window ends and develop systemic symptoms, call 911. The deviation should be documented and the allergist should assess dose protocols before the next injection visit.
Can I request my allergy shot be given in the thigh or non-standard site?
The upper outer arm (posterolateral deltoid) is the standard SCIT injection site per Cox 2011 PP3 Summary Statement 13, and deviating from this standard requires clinical justification. In rare circumstances — such as patients with bilateral upper-arm anatomical contraindications or certain pediatric situations — alternative sites may be considered, but this requires explicit allergist authorization and documentation. Patients should not request non-standard injection sites based on personal preference, as the posterolateral deltoid was selected specifically for its favorable subcutaneous fat depth, neurovascular safety, and accessibility. If you have a clinical reason why the upper outer arm is not feasible, discuss it explicitly with your allergist before the injection visit.
Are there situations where the standard injection site guidelines do not apply?
The Cox 2011 PP3 injection-site guidelines apply to conventional aqueous SCIT for adults and children ≥5 years old. Venom immunotherapy (VIT) follows the same anatomical guidelines (subcutaneous, upper outer arm) per the AAAAI Stinging Insect Hypersensitivity Practice Parameter, though VIT concentrations and build-up schedules differ from aeroallergen SCIT. Children under 5 are not routinely enrolled in SCIT (Cox 2011 PP3), and very young or small patients who are treated in specialized centers may have individualized injection-site protocols. Cluster and rush SCIT protocols use the same injection site but different dose escalation schedules. The fundamental site rule — subcutaneous posterolateral deltoid, alternating arms, with 30-minute observation — applies across all conventional SCIT protocols.
Related Articles
Allergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAre Allergy Shots Better Than Pills? | Curex Guide
For moderate-to-severe allergies, yes: SCIT is disease-modifying (Cochrane SMD −0.73). Pills suppress symptoms only — stop the pill, symptoms return. Full comparison inside.
Read moreAre Allergy Shots Permanent? | Curex Allergy Shot Guide
Allergy shots are disease-modifying, not permanent — Durham 1999 NEJM: 3-yr grass SCIT gives 3+ yr remission post-stop. Relapse 0–55% by allergen.
Read moreAllergy Shots for Seasonal Allergies | Curex Guide
Yes, allergy shots work for seasonal allergies — Cochrane 51 RCTs found symptom SMD −0.73. Learn who qualifies, what the commitment is, and what 23.9% dropout means.
Read moreCat Allergy Shots for Humans | Curex SCIT Guide
Cat allergy shots use FDA-standardized Fel d 1 extract for ~72% symptom relief. RCT evidence, schedule, plus at-home SCIT from Curex at $129/mo.
Read moreWhere To Give Allergy Shots | Curex Allergy Shot Guide
Give allergy shots SC in the upper outer arm (posterolateral deltoid), 26-27G ½-inch, alternating arms. At-home SCIT with Curex at $129/mo.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.